Trial · NCT02795117
Comparative Safety and Efficacy of Two Treatments in the Treatment of Inflammatory Lesions of Rosacea
NCT02795117, Phase 3, Completed, Padagis LLC; results first posted 2021-01-05
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Comparative Safety and Efficacy of Two Treatments in the Treatment of Inflammatory Lesions of Rosacea. Trials, record NCT02795117. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT02795117
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Comparative Safety and Efficacy of Two Treatments in the Treatment of Inflammatory Lesions of Rosacea
- NCT number
- NCT02795117
- Status
- Completed
- Phases
- Phase 3
- Enrollment
- 486 participants, actual
- Lead sponsor
- Padagis LLC
- Conditions
- Rosacea
- Interventions
- Ivermectin, Ivermectin (reference), Placebo
- First posted
- 2016-06-09
- Last updated
- 2021-11-02
- Results first posted
- 2021-01-05
Source ClinicalTrials.gov
Registered outcomes2
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Mean Percent Change From Baseline in the Inflammatory (Papules and Pustules) Lesion Count | Day 1 to Day 84 | |
| Secondary | Subjects With Clinical Success on the Investigator Global Assessment | Day 1 to Day 84 | Clinical success is defined as a score of clear or almost clear |
Source ClinicalTrials.gov
Outcomes2
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | Mean Percent Change From Baseline in the Inflammatory (Papules and Pustules) Lesion Count | Day 1 to Day 84 | Per protocol population | percentage of lesion reduction | MEAN |
| SECONDARY | Subjects With Clinical Success on the Investigator Global Assessment | Day 1 to Day 84 | Per protocol population | Participants | COUNT_OF_PARTICIPANTS |
Source ClinicalTrials.gov
Results by group6
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Mean Percent Change From Baseline in the Inflammatory (Papules and Pustules) Lesion Count | Test Product | 65.47 | Standard Deviation 30.222 | percentage of lesion reduction | |
| Mean Percent Change From Baseline in the Inflammatory (Papules and Pustules) Lesion Count | Reference Product | 67.89 | Standard Deviation 30.244 | percentage of lesion reduction | |
| Mean Percent Change From Baseline in the Inflammatory (Papules and Pustules) Lesion Count | Placebo | 55.51 | Standard Deviation 32.660 | percentage of lesion reduction | |
| Subjects With Clinical Success on the Investigator Global Assessment | Test Product | 71 | Participants | ||
| Subjects With Clinical Success on the Investigator Global Assessment | Reference Product | 79 | Participants | ||
| Subjects With Clinical Success on the Investigator Global Assessment | Placebo | 26 | Participants |
Source ClinicalTrials.gov
Participant flow9
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Overall Study | STARTED | Test Product | 193 | |
| Overall Study | STARTED | Reference Product | 193 | |
| Overall Study | STARTED | Placebo | 100 | |
| Overall Study | COMPLETED | Test Product | 175 | |
| Overall Study | COMPLETED | Reference Product | 166 | |
| Overall Study | COMPLETED | Placebo | 88 | |
| Overall Study | NOT COMPLETED | Test Product | 18 | |
| Overall Study | NOT COMPLETED | Reference Product | 27 | |
| Overall Study | NOT COMPLETED | Placebo | 12 |
Source ClinicalTrials.gov
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals9
The totals the trial posted for each group.
| Total | Group | Affected | At risk |
|---|---|---|---|
| Total, all-cause mortality | Test Product | 0 | 193 |
| Total, all-cause mortality | Reference Product | 0 | 193 |
| Total, all-cause mortality | Placebo | 0 | 100 |
| Total, other adverse events | Test Product | 0 | 193 |
| Total, other adverse events | Reference Product | 0 | 193 |
| Total, other adverse events | Placebo | 0 | 100 |
| Total, serious adverse events | Test Product | 0 | 193 |
| Total, serious adverse events | Reference Product | 0 | 193 |
| Total, serious adverse events | Placebo | 0 | 100 |
Source ClinicalTrials.gov
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT02795117
GET https://conductscience.org/api/trials/v1/NCT02795117/registered